Evaluation of a low-pass whole genome sequencing-based solution for homologous recombination deficiency detection supported by deep learning algorithms
About
Part 1: Homologous Recombination Deficiency (HRD) Detection
Originally presented at ESMO 2022
What’s New? CE-IVD Oncology Applications by SOPHiA GENETICS™
Alexander Kurze, PhD
Evaluation of a low-pass whole genome sequencing-based solution for homologous recombination deficiency detection supported by deep learning algorithms
Dr. Adrien Buisson
Evaluation of a low-pass whole genome sequencing-based solution for homologous recombination deficiency detection supported by deep learning algorithms
Presenters
SOPHiA GENETICS
Alexander Kurze, PhD
Senior Director Product Management, SOPHiA GENETICS
Dr. Adrien Buisson
Praticien Spécialiste des CLCC – UF de Biologie des Tumeurs, Centre Léon Bérard- Cheney